Hepatitis Forums

Hepatitis B Main Forums => Hepatitis B => Topic started by: Hep Editors on July 21, 2017, 10:41:58 am

Title: Does Hepatitis B Treatment Lower the Risk of Liver Cancer?
Post by: Hep Editors on July 21, 2017, 10:41:58 am

Over the long term, antiviral treatment for hepatitis B virus (HBV) should reduce the number of people who develop hepatocellular carcinoma (HCC), a form of primary liver cancer. But in the meantime, a decline in deaths due to other types of liver disease, such as decompensated cirrhosis, could mean that more people with hepatitis B will live long enough to develop liver cancer.

These paradoxical findings come from two studies recently published in Hepatology. A European study found that the risk of developing HCC decreased after five years of treatment with Viread (tenofovir disoproxil fumarate) or Baraclude (entecavir). But a Korean study found that while overall liver disease mortality has fallen dramatically since the debut of the first antivirals for HBV, liver cancer deaths continue to increase.

For more...
https://www.hepmag.com/article/hepatitis-b-treatment-lower-risk-liver-cancer